The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.34 billion in 2025 to $2.52 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to global tuberculosis disease burden, expansion of public health screening programs, availability of smear microscopy infrastructure, international funding for tb control, adoption of culture-based diagnostics.
The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for rapid and accurate tb diagnosis, rising focus on drug-resistant tb detection, expansion of decentralized diagnostic testing, increasing investments in molecular diagnostics, integration of ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of molecular tb testing methods, rising use of rapid diagnostic platforms, growing integration of drug resistance detection, expansion of point-of-care tb testing, enhanced focus on high-sensitivity diagnostics.
The increasing incidence of tuberculosis is expected to drive demand for tuberculosis diagnostics going forward. Tuberculosis (TB) is a highly contagious bacterial infection that primarily affects the lungs and requires prompt identification to prevent serious health complications and further transmission. The growing burden of tuberculosis is largely attributed to the rising prevalence of HIV/AIDS, which weakens the immune system and significantly increases susceptibility to developing active TB disease. This rising incidence is supporting the adoption of tuberculosis diagnostic solutions by increasing the need for rapid, accurate, and point-of-care testing that enables early initiation of treatment and improved disease management. For instance, in October 2025, according to the UK Health Security Agency, a government body responsible for health security in England, tuberculosis cases in England rose by 13.6 percent in 2024 compared to 2023, with 5,490 reported cases in 2024 versus 4,831 cases in the previous year. Therefore, the growing incidence of tuberculosis is contributing to the expansion of the tuberculosis diagnostics market.
Leading companies operating in the tuberculosis diagnostics space are prioritizing product innovation and the development of advanced diagnostic solutions to strengthen their market presence. Tuberculosis diagnostic tests include a range of medical assessments and laboratory methods used to determine whether an individual is infected with Mycobacterium tuberculosis, the bacterium responsible for TB. These tests are critical for identifying active tuberculosis, latent infections, and drug-resistant strains, allowing timely and appropriate treatment interventions. For example, in February 2023, Redcliffe Labs, an India-based technology-enabled diagnostics service provider, launched the BD MAX MDR TB test, a diagnostic solution designed to help clinicians rapidly detect tuberculosis and multidrug resistance as a first-line test. Conducted on the BD MAX molecular diagnostic system, the test enables simultaneous detection of TB-causing bacteria and identification of genetic mutations associated with resistance to two key first-line drugs, isoniazid (INH) and rifampicin (RIF).
In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.0 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.
Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio.
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the tuberculosis diagnostics market by increasing costs of imported reagents, diagnostic kits, molecular testing instruments, imaging components, and laboratory consumables. Public health systems and diagnostic laboratories in low- and middle-income regions are most affected due to dependence on imported testing supplies, while developed markets face higher equipment costs. These tariffs are raising testing expenses and affecting screening coverage. However, they are also encouraging local manufacturing of diagnostic kits, regional reagent production, and technology transfer initiatives supporting long-term diagnostic capacity building.
The tuberculosis diagnostics market research report is one of a series of new reports that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.
The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician’s office laboratories, reference laboratories, academic institutions, and research facilities.
The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing demand for rapid and accurate tb diagnosis, rising focus on drug-resistant tb detection, expansion of decentralized diagnostic testing, increasing investments in molecular diagnostics, integration of ai-assisted diagnostic tools. Major trends in the forecast period include increasing adoption of molecular tb testing methods, rising use of rapid diagnostic platforms, growing integration of drug resistance detection, expansion of point-of-care tb testing, enhanced focus on high-sensitivity diagnostics.
The increasing incidence of tuberculosis is expected to drive demand for tuberculosis diagnostics going forward. Tuberculosis (TB) is a highly contagious bacterial infection that primarily affects the lungs and requires prompt identification to prevent serious health complications and further transmission. The growing burden of tuberculosis is largely attributed to the rising prevalence of HIV/AIDS, which weakens the immune system and significantly increases susceptibility to developing active TB disease. This rising incidence is supporting the adoption of tuberculosis diagnostic solutions by increasing the need for rapid, accurate, and point-of-care testing that enables early initiation of treatment and improved disease management. For instance, in October 2025, according to the UK Health Security Agency, a government body responsible for health security in England, tuberculosis cases in England rose by 13.6 percent in 2024 compared to 2023, with 5,490 reported cases in 2024 versus 4,831 cases in the previous year. Therefore, the growing incidence of tuberculosis is contributing to the expansion of the tuberculosis diagnostics market.
Leading companies operating in the tuberculosis diagnostics space are prioritizing product innovation and the development of advanced diagnostic solutions to strengthen their market presence. Tuberculosis diagnostic tests include a range of medical assessments and laboratory methods used to determine whether an individual is infected with Mycobacterium tuberculosis, the bacterium responsible for TB. These tests are critical for identifying active tuberculosis, latent infections, and drug-resistant strains, allowing timely and appropriate treatment interventions. For example, in February 2023, Redcliffe Labs, an India-based technology-enabled diagnostics service provider, launched the BD MAX MDR TB test, a diagnostic solution designed to help clinicians rapidly detect tuberculosis and multidrug resistance as a first-line test. Conducted on the BD MAX molecular diagnostic system, the test enables simultaneous detection of TB-causing bacteria and identification of genetic mutations associated with resistance to two key first-line drugs, isoniazid (INH) and rifampicin (RIF).
In August 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for approximately $24.0 per share, totaling over $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by utilizing Abcam plc's extensive portfolio of high-quality reagents and antibodies. This will enhance Danaher's capabilities in scientific research and development, allowing it to better meet the growing demand for advanced biological research tools. Abcam plc, a UK-based biotechnology company, also provides tuberculosis diagnostics.
Major companies operating in the tuberculosis diagnostics market are Beckton Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Rad Laboratories India Pvt.Ltd, Zhejiang Di'an Diagnostics Technology Co. Ltd, Kindstar Global, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Meridian Bioscience, Abbott Laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Bio Certica, BixBio.
Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2025. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tuberculosis diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the tuberculosis diagnostics market by increasing costs of imported reagents, diagnostic kits, molecular testing instruments, imaging components, and laboratory consumables. Public health systems and diagnostic laboratories in low- and middle-income regions are most affected due to dependence on imported testing supplies, while developed markets face higher equipment costs. These tariffs are raising testing expenses and affecting screening coverage. However, they are also encouraging local manufacturing of diagnostic kits, regional reagent production, and technology transfer initiatives supporting long-term diagnostic capacity building.
The tuberculosis diagnostics market research report is one of a series of new reports that provides tuberculosis diagnostics market statistics, including tuberculosis diagnostics industry global market size, regional shares, competitors with a tuberculosis diagnostics market share, detailed tuberculosis diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the tuberculosis diagnostics industry. This tuberculosis diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Tuberculosis diagnostics encompass tools or tests characterized by high sensitivity and specificity in diagnosing TB and monitoring treatment effectiveness. They aim to identify acid-fast bacilli (AFB) in clinical samples and detect tuberculosis.
The tuberculosis diagnostics market comprises various types of tests such as radiographic testing, laboratory testing, nucleic acid testing, cytokine detection testing, drug resistance testing, skin test (TST)/Mantoux test, blood/serology tests, smear microscopy tests, cell culture-based tests, and other methods. Radiographic tests are utilized to identify chest abnormalities indicative of tuberculosis symptoms. These tests focus on diagnosing lesions that can manifest anywhere in the lungs, differing in cavitation, density, size, and shape. These diagnostic methods encompass nucleic acid testing (NAT), skin testing or Mantoux test (TST), blood testing or serology tests, smear microscopy, cultured-based tests, radiography tests, and other approaches. They serve various disease stages such as latent tuberculosis and active tuberculosis. End-users of tuberculosis diagnostics include hospitals, diagnostic laboratories, physician’s office laboratories, reference laboratories, academic institutions, and research facilities.
The tuberculosis diagnostics market includes revenues earned by entities by providing services related to diagnostic laboratory methods, detection of latent infection, detection of drug resistance, and diagnostic laboratory testings. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Tuberculosis Diagnostics Market Characteristics
3. Tuberculosis Diagnostics Market Supply Chain Analysis
4. Global Tuberculosis Diagnostics Market Trends and Strategies
5. Tuberculosis Diagnostics Market Analysis of End Use Industries
7. Global Tuberculosis Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Tuberculosis Diagnostics Total Addressable Market (TAM) Analysis for the Market
9. Tuberculosis Diagnostics Market Segmentation
10. Tuberculosis Diagnostics Market Regional and Country Analysis
11. Asia-Pacific Tuberculosis Diagnostics Market
12. China Tuberculosis Diagnostics Market
13. India Tuberculosis Diagnostics Market
14. Japan Tuberculosis Diagnostics Market
15. Australia Tuberculosis Diagnostics Market
16. Indonesia Tuberculosis Diagnostics Market
17. South Korea Tuberculosis Diagnostics Market
18. Taiwan Tuberculosis Diagnostics Market
19. South East Asia Tuberculosis Diagnostics Market
20. Western Europe Tuberculosis Diagnostics Market
21. UK Tuberculosis Diagnostics Market
22. Germany Tuberculosis Diagnostics Market
23. France Tuberculosis Diagnostics Market
24. Italy Tuberculosis Diagnostics Market
25. Spain Tuberculosis Diagnostics Market
26. Eastern Europe Tuberculosis Diagnostics Market
27. Russia Tuberculosis Diagnostics Market
28. North America Tuberculosis Diagnostics Market
29. USA Tuberculosis Diagnostics Market
30. Canada Tuberculosis Diagnostics Market
31. South America Tuberculosis Diagnostics Market
32. Brazil Tuberculosis Diagnostics Market
33. Middle East Tuberculosis Diagnostics Market
34. Africa Tuberculosis Diagnostics Market
36. Tuberculosis Diagnostics Market Competitive Landscape and Company Profiles
37. Tuberculosis Diagnostics Market Other Major and Innovative Companies
40. Tuberculosis Diagnostics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Tuberculosis Diagnostics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses tuberculosis diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for tuberculosis diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tuberculosis diagnostics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research Facilities
Subsegments:
1) By Radiographic Tests: Chest X-rays; CT Scans2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR); Nucleic Acid Amplification Tests (NAATs)
3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs)
4) By Drug Resistance Tests: GeneXpert MTB/RIF; Line Probe Assays
5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST)
6) By Blood Or Serology Test: Serological Tests for Antibodies
7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test
8) By Cell Culture-Based Tests: Solid Media Cultures; Liquid Media Cultures
9) By Other Test Types: Molecular Tests; Advanced Imaging Techniques
Companies Mentioned: Beckton Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation; PerkinElmer; Thermo Fisher Scientific Inc.; Creative Diagnostics; Lionex GmbH; Biocartis; Bio-Rad Laboratories India Pvt.Ltd; Zhejiang Di'an Diagnostics Technology Co. Ltd; Kindstar Global; Siemens AG; LumiraDx Limited; TestLine Clinical Diagnostics s.r.o.; Hologic; Meridian Bioscience; Abbott Laboratories Immunodiagnostic Systems Holdings PLC; Mesa Biotech Inc; Akonni Biosystems Inc; Epistem Limited; Gen-Probe; Bio Certica; BixBio
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Tuberculosis Diagnostics market report include:- Beckton Dickinson and Company
- F. Hoffmann-La Roche Ltd
- Qiagen N.V
- BioMerieux SA
- Danaher Corporation
- PerkinElmer
- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Lionex GmbH
- Biocartis
- Bio-Rad Laboratories India Pvt.Ltd
- Zhejiang Di'an Diagnostics Technology Co. Ltd
- Kindstar Global
- Siemens AG
- LumiraDx Limited
- TestLine Clinical Diagnostics s.r.o.
- Hologic
- Meridian Bioscience
- Abbott Laboratories Immunodiagnostic Systems Holdings PLC
- Mesa Biotech Inc
- Akonni Biosystems Inc
- Epistem Limited
- Gen-Probe
- Bio Certica
- BixBio
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.52 Billion |
| Forecasted Market Value ( USD | $ 3.37 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
